Literature DB >> 2206966

Speech therapy and Parkinson's disease: a review and further data.

J A Johnson1, T R Pring.   

Abstract

A review is undertaken of recent experimental studies of the effects of speech therapy offered to patients with Parkinson's disease. In contrast to earlier opinions based upon clinical impressions, the results of these studies indicate that the immediate gains from therapy measured within the clinical setting are readily detected, that these are perceived by patient's relatives and that there is reasonable evidence that benefits persist for some period after treatment. A further study is reported which tests the effects of a less intensive treatment regimen. This also gave positive results. Although questions remain regarding the most efficient form of treatment and the extent of its benefits outside the clinic, the existing results warrant greater optimism about the benefits of speech therapy offered to patients with Parkinson's disease.

Entities:  

Mesh:

Year:  1990        PMID: 2206966     DOI: 10.3109/13682829009011973

Source DB:  PubMed          Journal:  Br J Disord Commun        ISSN: 0007-098X


  10 in total

Review 1.  Targeted exercise therapy for voice and swallow in persons with Parkinson's disease.

Authors:  John A Russell; Michelle R Ciucci; Nadine P Connor; Timothy Schallert
Journal:  Brain Res       Date:  2010-03-15       Impact factor: 3.252

2.  A differential item functioning (DIF) analysis of the Communicative Participation Item Bank (CPIB): comparing individuals with Parkinson's disease from the United States and New Zealand.

Authors:  Carolyn Baylor; Megan J McAuliffe; Louise E Hughes; Kathryn Yorkston; Tim Anderson; Jiseon Kim; Dagmar Amtmann
Journal:  J Speech Lang Hear Res       Date:  2014-02       Impact factor: 2.297

3.  Intensive voice treatment (LSVT) for patients with Parkinson's disease: a 2 year follow up.

Authors:  L O Ramig; S Sapir; S Countryman; A A Pawlas; C O'Brien; M Hoehn; L L Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-10       Impact factor: 10.154

4.  The Acoustic Voice Quality Index (AVQI) in People with Parkinson's Disease Before and After Intensive Voice and Articulation Therapies: Secondary Outcome of a Randomized Controlled Trial.

Authors:  Gemma Moya-Galé; Jennifer Spielman; Lorraine A Ramig; Luca Campanelli; Youri Maryn
Journal:  J Voice       Date:  2022-04-18       Impact factor: 2.300

5.  Variables associated with communicative participation in Parkinson's disease and its relationship to measures of health-related quality-of-life.

Authors:  Megan J McAuliffe; Carolyn R Baylor; Kathryn M Yorkston
Journal:  Int J Speech Lang Pathol       Date:  2016-06-27       Impact factor: 2.484

6.  Lingual kinematics in dysarthric and nondysarthric speakers with Parkinson's disease.

Authors:  Min Ney Wong; Bruce E Murdoch; Brooke-Mai Whelan
Journal:  Parkinsons Dis       Date:  2011-10-09

7.  Lee Silverman voice treatment versus standard NHS speech and language therapy versus control in Parkinson's disease (PD COMM pilot): study protocol for a randomized controlled trial.

Authors:  Catherine M Sackley; Christina H Smith; Caroline Rick; Marian C Brady; Natalie Ives; Ramilla Patel; Helen Roberts; Francis Dowling; Sue Jowett; Keith Wheatley; Smitaa Patel; Debbie Kelly; Gina Sands; Carl Clarke
Journal:  Trials       Date:  2014-06-07       Impact factor: 2.279

Review 8.  Speech and language therapy versus placebo or no intervention for speech problems in Parkinson's disease.

Authors:  Clare P Herd; Claire L Tomlinson; Katherine H O Deane; Marian C Brady; Christina H Smith; Catherine M Sackley; Carl E Clarke
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

9.  Lee Silverman Voice Treatment versus standard speech and language therapy versus control in Parkinson's disease: a pilot randomised controlled trial (PD COMM pilot).

Authors:  Catherine M Sackley; Christina H Smith; Caroline E Rick; Marian C Brady; Natalie Ives; Smitaa Patel; Rebecca Woolley; Francis Dowling; Ramilla Patel; Helen Roberts; Sue Jowett; Keith Wheatley; Debbie Kelly; Gina Sands; Carl E Clarke
Journal:  Pilot Feasibility Stud       Date:  2018-01-10

10.  A multicentre, randomised controlled trial to compare the clinical and cost-effectiveness of Lee Silverman Voice Treatment versus standard NHS Speech and Language Therapy versus control in Parkinson's disease: a study protocol for a randomised controlled trial.

Authors:  C M Sackley; C Rick; P Au; M C Brady; G Beaton; C Burton; M Caulfield; S Dickson; F Dowling; M Hughes; N Ives; S Jowett; P Masterson-Algar; A Nicoll; S Patel; C H Smith; R Woolley; C E Clarke
Journal:  Trials       Date:  2020-05-27       Impact factor: 2.279

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.